Current Value
$158.001 Year Return
Current Value
$158.001 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TECH | 74.92% | $8.08B | -33.45% | 0.62% |
ICLR | 74.68% | $11.75B | -54.49% | 0.00% |
CRL | 74.44% | $7.42B | -29.34% | 0.00% |
A | 72.87% | $34.01B | -10.09% | 0.81% |
TMO | 70.50% | $156.72B | -27.89% | 0.39% |
RVTY | 70.25% | $11.32B | -14.64% | 0.29% |
MTD | 69.73% | $24.79B | -18.26% | 0.00% |
BRKR | 67.51% | $6.02B | -40.01% | 0.38% |
MEDP | 66.77% | $8.69B | -25.12% | 0.00% |
DHR | 66.31% | $146.51B | -22.63% | 0.55% |
TXT | 63.87% | $13.87B | -11.20% | 0.10% |
WAT | 62.45% | $20.59B | +14.98% | 0.00% |
AZTA | 61.68% | $1.41B | -45.19% | 0.00% |
BIO | 61.08% | $6.26B | -18.74% | 0.00% |
IT | 60.15% | $31.83B | -5.11% | 0.00% |
FTV | 58.52% | $24.23B | -3.45% | 0.45% |
TRMB | 57.14% | $17.31B | +29.33% | 0.00% |
ASH | 57.03% | $2.43B | -46.79% | 3.16% |
ESI | 56.98% | $5.27B | -19.33% | 1.49% |
ILMN | 56.94% | $13.86B | -17.20% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -14.90% | $5.10K | -99.92% | 0.00% |
CBOE | -8.25% | $23.34B | +31.58% | 1.12% |
VSTA | -7.55% | $331.23M | +31.32% | 0.00% |
LTM | -7.53% | $12.15B | -96.20% | 2.54% |
UUU | -7.51% | $7.36M | +96.30% | 0.00% |
CPSH | -6.19% | $39.37M | +58.02% | 0.00% |
CME | -5.69% | $97.17B | +37.77% | 3.95% |
MVO | -5.45% | $66.70M | -36.89% | 21.27% |
DFDV | -3.82% | $380.05M | +2,345.35% | 0.00% |
PULM | -3.23% | $30.39M | +340.19% | 0.00% |
LITB | -2.99% | $21.77M | -74.81% | 0.00% |
AIFU | -2.90% | $3.36B | 0.00% | 0.00% |
MO | -2.48% | $100.92B | +30.61% | 6.82% |
STG | -2.45% | $32.24M | -0.16% | 0.00% |
K | -1.84% | $28.31B | +38.89% | 2.82% |
MSIF | -1.32% | $831.23M | +47.01% | 6.11% |
BTCT | -0.89% | $21.81M | +56.22% | 0.00% |
CIG.C | -0.68% | $2.55B | +23.82% | 0.00% |
BPT | -0.50% | $13.72M | -72.13% | 0.00% |
VSA | -0.34% | $8.67M | -17.07% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MKTX | -0.02% | $8.44B | +11.89% | 1.32% |
VSA | -0.34% | $8.67M | -17.07% | 0.00% |
AQB | 0.47% | $3.52M | -50.00% | 0.00% |
BPT | -0.50% | $13.72M | -72.13% | 0.00% |
CIG.C | -0.68% | $2.55B | +23.82% | 0.00% |
ZCMD | 0.85% | $26.26M | -13.33% | 0.00% |
PRPO | 0.89% | $16.74M | +87.63% | 0.00% |
BTCT | -0.89% | $21.81M | +56.22% | 0.00% |
MSIF | -1.32% | $831.23M | +47.01% | 6.11% |
SRRK | 1.59% | $3.13B | +251.54% | 0.00% |
VRCA | 1.59% | $57.62M | -92.74% | 0.00% |
CNK | 1.66% | $3.70B | +79.80% | 0.50% |
VHC | 1.68% | $37.77M | +135.71% | 0.00% |
K | -1.84% | $28.31B | +38.89% | 2.82% |
HUSA | 1.86% | $8.56M | -56.67% | 0.00% |
POAI | 2.04% | $8.93M | -25.97% | 0.00% |
SAND | 2.13% | $2.65B | +66.97% | 0.62% |
NEUE | 2.28% | $60.80M | +26.11% | 0.00% |
STG | -2.45% | $32.24M | -0.16% | 0.00% |
MO | -2.48% | $100.92B | +30.61% | 6.82% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPH | 76.19% | $750.03M | 0.4% |
BBH | 75.95% | $338.76M | 0.35% |
FHLC | 74.47% | $2.47B | 0.084% |
IBB | 74.36% | $5.26B | 0.45% |
FXH | 74.31% | $916.49M | 0.62% |
VHT | 74.24% | $15.54B | 0.09% |
IYH | 72.80% | $2.79B | 0.39% |
PBE | 72.19% | $228.06M | 0.58% |
MOAT | 71.16% | $12.89B | 0.47% |
XLV | 71.01% | $34.90B | 0.09% |
FBT | 69.57% | $1.04B | 0.54% |
IXJ | 69.46% | $3.82B | 0.41% |
DSTL | 68.69% | $1.85B | 0.39% |
SMOT | 68.27% | $385.78M | 0.49% |
XPH | 67.61% | $155.05M | 0.35% |
GNOM | 67.57% | $44.85M | 0.5% |
RSP | 67.46% | $72.14B | 0.2% |
FLQM | 67.26% | $1.65B | 0.3% |
RUNN | 67.04% | $353.59M | 0.58% |
QQQJ | 66.86% | $615.50M | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTM | -0.05% | $318.33M | 0.07% |
BSV | -0.08% | $38.06B | 0.03% |
TYA | 0.26% | $145.08M | 0.15% |
BNDX | -0.39% | $66.51B | 0.07% |
CORN | 0.39% | $47.58M | 0.2% |
CGSM | -0.56% | $685.61M | 0.25% |
FLMI | -0.61% | $694.76M | 0.3% |
STIP | -0.65% | $12.59B | 0.03% |
CMBS | 0.69% | $438.71M | 0.25% |
WEAT | -0.83% | $119.25M | 0.28% |
SCHR | -1.17% | $10.64B | 0.03% |
SPTI | -1.36% | $8.60B | 0.03% |
SMMU | 1.40% | $862.96M | 0.35% |
BILZ | 1.73% | $840.07M | 0.14% |
SPSK | 1.82% | $314.69M | 0.5% |
SHV | 1.84% | $20.33B | 0.15% |
CARY | 1.95% | $347.36M | 0.8% |
TDTT | -2.01% | $2.58B | 0.18% |
SHY | -2.07% | $23.87B | 0.15% |
VGIT | -2.08% | $31.30B | 0.04% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -51.22% | $107.71M | 0.59% |
VIXY | -51.10% | $178.15M | 0.85% |
BTAL | -37.87% | $297.88M | 1.43% |
IVOL | -31.76% | $357.32M | 1.02% |
FXY | -22.25% | $855.96M | 0.4% |
TPMN | -21.69% | $30.69M | 0.65% |
FTSD | -18.54% | $228.22M | 0.25% |
XONE | -17.83% | $639.23M | 0.03% |
SPTS | -15.68% | $5.78B | 0.03% |
XHLF | -14.96% | $1.64B | 0.03% |
CLIP | -14.02% | $1.50B | 0.07% |
SHYM | -13.83% | $324.00M | 0.35% |
FXE | -13.47% | $548.34M | 0.4% |
UDN | -13.08% | $145.02M | 0.78% |
UTWO | -12.60% | $374.45M | 0.15% |
SCHO | -11.97% | $10.89B | 0.03% |
BWX | -11.64% | $1.40B | 0.35% |
VGSH | -11.44% | $22.42B | 0.03% |
IBTG | -11.13% | $1.94B | 0.07% |
IBTH | -10.88% | $1.57B | 0.07% |
Double maintains 9 strategies that include IQV - IQVIA Holdings, Inc.
Yahoo
RESEARCH TRIANGLE PARK, N.C., June 11, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, unveils AI agents at GTC Paris. IQVIA’s new custom-built AI agents using NVIDIA technology are designed to enhance workflows and accelerate insights for life sciences. These live applications of agentic architectures illustrate how IQVIA AI and deep domain expertise are transforming
Yahoo
IQVIA Holdings (NYSE:IQV) experienced a 10% rise in share price over the last week, correlating with its recent developments, notably the dosing of the first patient in the RENEW Phase 2 trial and its strategic alliance with Sarah Cannon Research Institute to optimize oncology trials. These initiatives likely provided a positive sentiment boost, aligning well with the broader market momentum, as indices such as the S&P 500 also reached new highs. The market's anticipation over US-China trade...
MarketWatch
IQVIA Holdings Inc. stock outperforms competitors on strong trading day
Yahoo
DOCS slips 4.4% in a month despite strong Q4 results, margin gains and raised guidance -- is there a buying opportunity?
SeekingAlpha
Veeva Systems' strong Q1 FY2026 results highlight AI innovation and industry expertise. Click to read my full analysis of the VEEV stock.
Yahoo
Let’s dig into the relative performance of Repligen (NASDAQ:RGEN) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season.